Table 1.
Expression of the C1, C2, Bw4 and A3/A11 HLA class I epitopes in B-CLL patients and in NK cells used in the cytotoxicity assays shown in Fig. 2A.
| Sample | C1 | C2 | Bw4 | A3/A11 |
|---|---|---|---|---|
| CLL1 | + | − | + | − |
| CLL2 | + | − | + | − |
| CLL3 | + | + | + | N.D |
| CLL4 | + | + | + | − |
| CLL5 | + | + | + | − |
| CLL6 | + | − | + | − |
| CLL7 | + | + | + | − |
| CLL8 | + | − | + | − |
| CLL9 | + | − | + | + |
| CLL10 | + | − | − | + |
| CLL11 | + | − | + | − |
| CLL12 | + | − | + | − |
| CLL13 | − | + | + | + |
| CLL14 | + | − | + | − |
| CLL15 | + | − | + | − |
| CLL16 | + | − | + | − |
| CLL17 | + | − | N.D | − |
| CLL18 | + | − | + | + |
| CLL19 | + | − | + | − |
| CLL20 | + | − | − | − |
| CLL21 | N.D | N.D | N.D | − |
| CLL22 | + | + | + | − |
| NK1; NK2; NK8 | N.D | N.D | N.D | N.D |
| NK3 | + | + | − | − |
| NK4 | + | + | + | − |
| NK5 | + | + | − | + |
| NK6 | + | + | N.D | N.D |
| NK7 | + | − | + | + |
| NK9 | + | + | + | − |
| NK10 | + | + | + | − |